chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: COVID-19 immunisation
Clinical narrative: Patient took first shot of Pfizer and came back for a second shot and Moderna vaccine was mistakenly given as second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 IMMUNISATION (Patient took first shot of Pfizer and came back for a second shot and Moderna vaccine was mistakenly given as second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 21-May-2021, the patient experienced COVID-19 IMMUNISATION (Patient took first shot of Pfizer and came back for a second shot and Moderna vaccine was mistakenly given as second dose). At the time of the report, COVID-19 IMMUNISATION (Patient took first shot of Pfizer and came back for a second shot and Moderna vaccine was mistakenly given as second dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medication and treatment information was provided. Action taken with mRNA-123 is not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Side effects of the moderna; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects of the moderna) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced ADVERSE EVENT (Side effects of the moderna). At the time of the report, ADVERSE EVENT (Side effects of the moderna) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Less than a full dose was received by the patient.; Less than a full dose was received by the patient.; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Less than a full dose was received by the patient.) and DEVICE CONNECTION ISSUE (Less than a full dose was received by the patient.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016C21A and 023C21A .) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 21-May-2021, the patient experienced UNDERDOSE (Less than a full dose was received by the patient.). On an unknown date, the patient experienced DEVICE CONNECTION ISSUE (Less than a full dose was received by the patient.). At the time of the report, UNDERDOSE (Less than a full dose was received by the patient.) and DEVICE CONNECTION ISSUE (Less than a full dose was received by the patient.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No treatment information and concomitant medications were provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Joint swelling, Peripheral swelling
Clinical narrative: Swollen calves, ankles; red spots; Swollen calves, ankles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Swollen calves, ankles), ERYTHEMA (red spots) and PERIPHERAL SWELLING (Swollen calves, ankles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (Swollen calves, ankles), ERYTHEMA (red spots) and PERIPHERAL SWELLING (Swollen calves, ankles). At the time of the report, JOINT SWELLING (Swollen calves, ankles), ERYTHEMA (red spots) and PERIPHERAL SWELLING (Swollen calves, ankles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: joint pain after the shot; This spontaneous case was reported by a patient and describes the occurrence of ARTHRALGIA (joint pain after the shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (joint pain after the shot). At the time of the report, ARTHRALGIA (joint pain after the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided by reporter.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication, Vaccination site pain
Clinical narrative: Noxious with administration  first dose of Covid -19 vaccine; sore arm with administration first  dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Noxious with administration  first dose of Covid -19 vaccine) and VACCINATION SITE PAIN (sore arm with administration first  dose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION COMPLICATION (Noxious with administration  first dose of Covid -19 vaccine) and VACCINATION SITE PAIN (sore arm with administration first  dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (Noxious with administration  first dose of Covid -19 vaccine) and VACCINATION SITE PAIN (sore arm with administration first  dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-162068 (Patient Link).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hot flush, Myalgia
Clinical narrative: Soreness; headaches; muscle aches; chills; Fatigue; fever; Hot flashes; This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (Hot flashes), PAIN (Soreness), HEADACHE (headaches), MYALGIA (muscle aches) and CHILLS (chills) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 18-May-2021, the patient experienced HOT FLUSH (Hot flashes), HEADACHE (headaches), MYALGIA (muscle aches), CHILLS (chills), FATIGUE (Fatigue) and PYREXIA (fever). On an unknown date, the patient experienced PAIN (Soreness). At the time of the report, HOT FLUSH (Hot flashes), PAIN (Soreness), HEADACHE (headaches), MYALGIA (muscle aches), CHILLS (chills) and FATIGUE (Fatigue) outcome was unknown.            No relevant concomitant medication and treatment information was provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.    This case was linked to MOD-2021-162062 (Patient Link).
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Soreness; headaches; muscle aches; chills; Fatigue; fever; Hot flashes; This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (Hot flashes), PAIN (Soreness), HEADACHE (headaches), MYALGIA (muscle aches) and CHILLS (chills) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 18-May-2021, the patient experienced HOT FLUSH (Hot flashes), HEADACHE (headaches), MYALGIA (muscle aches), CHILLS (chills), FATIGUE (Fatigue) and PYREXIA (fever). On an unknown date, the patient experienced PAIN (Soreness). At the time of the report, HOT FLUSH (Hot flashes), PAIN (Soreness), HEADACHE (headaches), MYALGIA (muscle aches), CHILLS (chills) and FATIGUE (Fatigue) outcome was unknown.            No relevant concomitant medication and treatment information was provided.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.    This case was linked to MOD-2021-162062 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site coldness, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Felling of heat and extreme cold at the injection site; Felling of heat and extreme cold at the injection site; Itchiness at the arm of the injection; Swelling of the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE COLDNESS (Felling of heat and extreme cold at the injection site), VACCINATION SITE WARMTH (Felling of heat and extreme cold at the injection site), VACCINATION SITE PRURITUS (Itchiness at the arm of the injection) and VACCINATION SITE SWELLING (Swelling of the arm of the injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 13-May-2021, the patient experienced VACCINATION SITE COLDNESS (Felling of heat and extreme cold at the injection site), VACCINATION SITE WARMTH (Felling of heat and extreme cold at the injection site), VACCINATION SITE PRURITUS (Itchiness at the arm of the injection) and VACCINATION SITE SWELLING (Swelling of the arm of the injection). On 15-May-2021, VACCINATION SITE PRURITUS (Itchiness at the arm of the injection) had resolved. At the time of the report, VACCINATION SITE COLDNESS (Felling of heat and extreme cold at the injection site), VACCINATION SITE WARMTH (Felling of heat and extreme cold at the injection site) and VACCINATION SITE SWELLING (Swelling of the arm of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant was reported Treatment included Cold rags and topic anti-inflammatory balms were applied.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia
Clinical narrative: No energy; Pain in joints; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (No energy) and ARTHRALGIA (Pain in joints) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included Cancer (Patient was a cancer survivor.). Concomitant products included METOPROLOL and VITAMINS NOS for an unknown indication.   On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (No energy) and ARTHRALGIA (Pain in joints). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ASTHENIA (No energy) and ARTHRALGIA (Pain in joints) outcome was unknown.            Concomitant products used included Vitamins, metoprolol and stomach acid medications.  The patient experienced Pain in joints and no energy after 4-5 days of second dose.  Action taken with mRNA-123 is not applicable.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Malaise, Myalgia, Oropharyngeal pain, Pyrexia
Clinical narrative: sore throat; flu like symptoms; malaise; injection site pain; fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), INFLUENZA LIKE ILLNESS (flu like symptoms), MALAISE (malaise), VACCINATION SITE PAIN (injection site pain) and PYREXIA (fever) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LOSARTAN and FUROSEMIDE for Hypertension, APIXABAN (ELIQUIS) for an unknown indication.   On 20-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-May-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), INFLUENZA LIKE ILLNESS (flu like symptoms), MALAISE (malaise), VACCINATION SITE PAIN (injection site pain), PYREXIA (fever) and MYALGIA (body aches). At the time of the report, OROPHARYNGEAL PAIN (sore throat), INFLUENZA LIKE ILLNESS (flu like symptoms), MALAISE (malaise), VACCINATION SITE PAIN (injection site pain), PYREXIA (fever) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. Action taken with mRNA-123 is not applicable.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore throat; flu like symptoms; malaise; injection site pain; fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), INFLUENZA LIKE ILLNESS (flu like symptoms), MALAISE (malaise), VACCINATION SITE PAIN (injection site pain) and PYREXIA (fever) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LOSARTAN and FUROSEMIDE for Hypertension, APIXABAN (ELIQUIS) for an unknown indication.   On 20-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-May-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), INFLUENZA LIKE ILLNESS (flu like symptoms), MALAISE (malaise), VACCINATION SITE PAIN (injection site pain), PYREXIA (fever) and MYALGIA (body aches). At the time of the report, OROPHARYNGEAL PAIN (sore throat), INFLUENZA LIKE ILLNESS (flu like symptoms), MALAISE (malaise), VACCINATION SITE PAIN (injection site pain), PYREXIA (fever) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. Action taken with mRNA-123 is not applicable.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Fatigue, Loss of personal independence in daily activities, Myalgia
Clinical narrative: legs are so sore; So much pain; Tired; Muscles sore; Woozy; Didn't have balance; Barely got to bathroom; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Woozy), BALANCE DISORDER (Didn't have balance), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Barely got to bathroom), PAIN IN EXTREMITY (legs are so sore) and PAIN (So much pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced DIZZINESS (Woozy), BALANCE DISORDER (Didn't have balance), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Barely got to bathroom), FATIGUE (Tired) and MYALGIA (Muscles sore). On an unknown date, the patient experienced PAIN IN EXTREMITY (legs are so sore) and PAIN (So much pain). At the time of the report, DIZZINESS (Woozy), BALANCE DISORDER (Didn't have balance), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Barely got to bathroom), PAIN IN EXTREMITY (legs are so sore), PAIN (So much pain), FATIGUE (Tired) and MYALGIA (Muscles sore) outcome was unknown.            No concomitant products information is provided  No treatment products information is provided
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: legs are so sore; So much pain; Tired; Muscles sore; Woozy; Didn't have balance; Barely got to bathroom; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Woozy), BALANCE DISORDER (Didn't have balance), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Barely got to bathroom), PAIN IN EXTREMITY (legs are so sore) and PAIN (So much pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced DIZZINESS (Woozy), BALANCE DISORDER (Didn't have balance), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Barely got to bathroom), FATIGUE (Tired) and MYALGIA (Muscles sore). On an unknown date, the patient experienced PAIN IN EXTREMITY (legs are so sore) and PAIN (So much pain). At the time of the report, DIZZINESS (Woozy), BALANCE DISORDER (Didn't have balance), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Barely got to bathroom), PAIN IN EXTREMITY (legs are so sore), PAIN (So much pain), FATIGUE (Tired) and MYALGIA (Muscles sore) outcome was unknown.            No concomitant products information is provided  No treatment products information is provided
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pains) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 1. On an unknown date, the patient experienced ARTHRALGIA (Joint pains). At the time of the report, ARTHRALGIA (Joint pains) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Chills, Dyspnoea, Headache
Clinical narrative: Could be tendon pain; Short of breath when wasn't before; Sneezing; Teary eyes; Could be allergies; Chest anxiety feeling of; Pain goes into the shoulder too (left arm); Left arm is painful and everything hurts in that arm (left arm); Headaches for 2-3 days, never had before; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TENDON PAIN (Could be tendon pain), DYSPNOEA (Short of breath when wasn't before), SNEEZING (Sneezing), LACRIMATION INCREASED (Teary eyes) and HYPERSENSITIVITY (Could be allergies) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Glaucoma since 2000. Concomitant products included NETARSUDIL MESILATE (RHOPRESSA), BIMATOPROST (LUMIGAN), DORZOLAMIDE and TIMOLOL for Glaucoma.   On 27-Mar-2021 at 5:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021 at 5:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced CHILLS (Chills). On an unknown date, the patient experienced TENDON PAIN (Could be tendon pain), DYSPNOEA (Short of breath when wasn't before), SNEEZING (Sneezing), LACRIMATION INCREASED (Teary eyes), HYPERSENSITIVITY (Could be allergies), CHEST DISCOMFORT (Chest anxiety feeling of), ARTHRALGIA (Pain goes into the shoulder too (left arm)), MYALGIA (Left arm is painful and everything hurts in that arm (left arm)) and HEADACHE (Headaches for 2-3 days, never had before). The patient was treated with IBUPROFEN (IBUPROFEN MAX) in May 2021 for Adverse event, at a dose of UNK UNK, bid. At the time of the report, TENDON PAIN (Could be tendon pain) and ARTHRALGIA (Pain goes into the shoulder too (left arm)) had not resolved, DYSPNOEA (Short of breath when wasn't before), SNEEZING (Sneezing), LACRIMATION INCREASED (Teary eyes), HYPERSENSITIVITY (Could be allergies), CHEST DISCOMFORT (Chest anxiety feeling of), MYALGIA (Left arm is painful and everything hurts in that arm (left arm)) and HEADACHE (Headaches for 2-3 days, never had before) outcome was unknown and CHILLS (Chills) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-JUN-2021 contains significant information-Patient demographics, therapy details of suspect product updated and outcome of the event Pain goes into the shoulder too (left arm) updated to not resolved.,
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Lacrimation increased, Myalgia, Sneezing, Tendon pain
Clinical narrative: Could be tendon pain; Short of breath when wasn't before; Sneezing; Teary eyes; Could be allergies; Chest anxiety feeling of; Pain goes into the shoulder too (left arm); Left arm is painful and everything hurts in that arm (left arm); Headaches for 2-3 days, never had before; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TENDON PAIN (Could be tendon pain), DYSPNOEA (Short of breath when wasn't before), SNEEZING (Sneezing), LACRIMATION INCREASED (Teary eyes) and HYPERSENSITIVITY (Could be allergies) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Glaucoma since 2000. Concomitant products included NETARSUDIL MESILATE (RHOPRESSA), BIMATOPROST (LUMIGAN), DORZOLAMIDE and TIMOLOL for Glaucoma.   On 27-Mar-2021 at 5:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Apr-2021 at 5:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced CHILLS (Chills). On an unknown date, the patient experienced TENDON PAIN (Could be tendon pain), DYSPNOEA (Short of breath when wasn't before), SNEEZING (Sneezing), LACRIMATION INCREASED (Teary eyes), HYPERSENSITIVITY (Could be allergies), CHEST DISCOMFORT (Chest anxiety feeling of), ARTHRALGIA (Pain goes into the shoulder too (left arm)), MYALGIA (Left arm is painful and everything hurts in that arm (left arm)) and HEADACHE (Headaches for 2-3 days, never had before). The patient was treated with IBUPROFEN (IBUPROFEN MAX) in May 2021 for Adverse event, at a dose of UNK UNK, bid. At the time of the report, TENDON PAIN (Could be tendon pain) and ARTHRALGIA (Pain goes into the shoulder too (left arm)) had not resolved, DYSPNOEA (Short of breath when wasn't before), SNEEZING (Sneezing), LACRIMATION INCREASED (Teary eyes), HYPERSENSITIVITY (Could be allergies), CHEST DISCOMFORT (Chest anxiety feeling of), MYALGIA (Left arm is painful and everything hurts in that arm (left arm)) and HEADACHE (Headaches for 2-3 days, never had before) outcome was unknown and CHILLS (Chills) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-JUN-2021 contains significant information-Patient demographics, therapy details of suspect product updated and outcome of the event Pain goes into the shoulder too (left arm) updated to not resolved.,
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Sore arm; This spontaneous case was reported by a patient family member or friend and describes the occurrence of MYALGIA (Sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore arm). At the time of the report, MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-161828, MOD-2021-161828 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: On 24-may-2021, Pictures of the vaccination card and events caused due to vaccination were attached .
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Blur; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blur) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     no medical history was provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VISION BLURRED (Blur). At the time of the report, VISION BLURRED (Blur) outcome was unknown.            No concomitant medication was reported , No treatment medication was reported .   Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Induration, Swelling, Vaccination site reaction
Clinical narrative: COVID arm; red; Hard; Swollen; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE REACTION (COVID arm), ERYTHEMA (red), INDURATION (Hard) and SWELLING (Swollen) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced VACCINATION SITE REACTION (COVID arm), ERYTHEMA (red), INDURATION (Hard) and SWELLING (Swollen). At the time of the report, VACCINATION SITE REACTION (COVID arm), ERYTHEMA (red), INDURATION (Hard) and SWELLING (Swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment information was provided by the reporter
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: severe pain in arm / still experiencing a sore arm / arm functions but it is still sore and it hurts when tries to; Fever (102); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in arm / still experiencing a sore arm / arm functions but it is still sore and it hurts when tries to) and PYREXIA (Fever (102)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced PAIN IN EXTREMITY (severe pain in arm / still experiencing a sore arm / arm functions but it is still sore and it hurts when tries to). 27-Apr-2021, the patient experienced PYREXIA (Fever (102)). At the time of the report, PAIN IN EXTREMITY (severe pain in arm / still experiencing a sore arm / arm functions but it is still sore and it hurts when tries to) and PYREXIA (Fever (102)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medications were provided.  No Treatment information were provided   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up information included additional event included fever and outcome of the earlier reported event (pain in arm).
Sex: U
Vaccine: COVID19
Symptoms: Epistaxis, Feeling abnormal
Clinical narrative: Heavy nose bleed and then Light nose bleed; Patient feeling real bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Patient feeling real bad) and EPISTAXIS (Heavy nose bleed and then Light nose bleed) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 038A21A) for COVID-19 vaccination.     The patient's past medical history included Nose bleed (Nose bleeds but not since patient was young.).   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced FEELING ABNORMAL (Patient feeling real bad). On 21-May-2021, the patient experienced EPISTAXIS (Heavy nose bleed and then Light nose bleed). At the time of the report, FEELING ABNORMAL (Patient feeling real bad) and EPISTAXIS (Heavy nose bleed and then Light nose bleed) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment medications were not provided.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Product administration interrupted
Clinical narrative: It's been more than a month since he received the first dose (>42 days); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (It's been more than a month since he received the first dose (>42 days)) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (It's been more than a month since he received the first dose (>42 days)). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (It's been more than a month since he received the first dose (>42 days)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Sore arm; Mild body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and MYALGIA (Mild body aches) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and MYALGIA (Mild body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) and MYALGIA (Mild body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.   This case was linked to MOD-2021-162013 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: joint pain; arm was really sore; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (arm was really sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (arm was really sore). At the time of the report, ARTHRALGIA (joint pain) and VACCINATION SITE PAIN (arm was really sore) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient received a 3rd dose of Moderna Covid-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXTRA DOSE ADMINISTERED (Patient received a 3rd dose of Moderna Covid-19 vaccine) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced EXTRA DOSE ADMINISTERED (Patient received a 3rd dose of Moderna Covid-19 vaccine). On 21-May-2021, EXTRA DOSE ADMINISTERED (Patient received a 3rd dose of Moderna Covid-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19 immunisation
Clinical narrative: first dose was pfizer and second dose was moderna; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 IMMUNISATION (first dose was pfizer and second dose was moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, the patient experienced COVID-19 IMMUNISATION (first dose was pfizer and second dose was moderna). On 20-May-2021, COVID-19 IMMUNISATION (first dose was pfizer and second dose was moderna) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: reporter information added On 25-May-2021: reporter information added
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Bronchospasm, Cardiac flutter, Chest discomfort
Clinical narrative: Bronchospasm; Irregular heart rate/palpitations; Flutter in heart; Chest pressure; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FLUTTER (Flutter in heart), CHEST DISCOMFORT (Chest pressure), COUGH (Coughing), BRONCHOSPASM (Bronchospasm) and PALPITATIONS (Irregular heart rate/palpitations) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included METOPROLOL and EPINEPHRINE for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced CARDIAC FLUTTER (Flutter in heart), CHEST DISCOMFORT (Chest pressure) and COUGH (Coughing). On 28-Apr-2021, the patient experienced BRONCHOSPASM (Bronchospasm) and PALPITATIONS (Irregular heart rate/palpitations). At the time of the report, CARDIAC FLUTTER (Flutter in heart), CHEST DISCOMFORT (Chest pressure), COUGH (Coughing), BRONCHOSPASM (Bronchospasm) and PALPITATIONS (Irregular heart rate/palpitations) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, Body temperature: 97.6 (Inconclusive) 97.6. On 13-May-2021, Heart rate: 45 (Inconclusive) 45 beats per minute. On 14-May-2021, Heart rate: 53 (Inconclusive) 53 beats per minute. On 23-May-2021, Blood pressure measurement: 144/90 mmHg (Inconclusive) 144/90. On 23-May-2021, Heart rate: 51 (Inconclusive) 51 beats per minute. On 15-Jun-2021, Blood pressure measurement: 147/64 mmHg (Inconclusive) 147/64 and 97/64 mmHg (Inconclusive) 97/64. In 2021, Body temperature: 97.6 (Inconclusive) 97.6. In 2021, Electrocardiogram: abnormal ekg in urgent care, er and cardiologist o (abnormal) Abnormal EKG in urgent care, ER and cardiologist office.. On 15-Jun-2021, Heart rate: 48 (Inconclusive) 48 beats per minute and 48 (Inconclusive) 48 beats per minute. On 21-Jun-2021, Blood pressure measurement: 111/78 mmHg (Inconclusive) 111/78 and 112/77 mmHg (Inconclusive) 112/77. On 21-Jun-2021, Heart rate: 45 (Inconclusive) 45 beats per minute and 45 (Inconclusive) 45 beats per minute.         No concomitant drugs were reported.   No treatment information was reported.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up significant contain information of patient demographics, new events, treatment; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Heart rate, Palpitations
Clinical narrative: Bronchospasm; Irregular heart rate/palpitations; Flutter in heart; Chest pressure; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC FLUTTER (Flutter in heart), CHEST DISCOMFORT (Chest pressure), COUGH (Coughing), BRONCHOSPASM (Bronchospasm) and PALPITATIONS (Irregular heart rate/palpitations) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included METOPROLOL and EPINEPHRINE for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced CARDIAC FLUTTER (Flutter in heart), CHEST DISCOMFORT (Chest pressure) and COUGH (Coughing). On 28-Apr-2021, the patient experienced BRONCHOSPASM (Bronchospasm) and PALPITATIONS (Irregular heart rate/palpitations). At the time of the report, CARDIAC FLUTTER (Flutter in heart), CHEST DISCOMFORT (Chest pressure), COUGH (Coughing), BRONCHOSPASM (Bronchospasm) and PALPITATIONS (Irregular heart rate/palpitations) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, Body temperature: 97.6 (Inconclusive) 97.6. On 13-May-2021, Heart rate: 45 (Inconclusive) 45 beats per minute. On 14-May-2021, Heart rate: 53 (Inconclusive) 53 beats per minute. On 23-May-2021, Blood pressure measurement: 144/90 mmHg (Inconclusive) 144/90. On 23-May-2021, Heart rate: 51 (Inconclusive) 51 beats per minute. On 15-Jun-2021, Blood pressure measurement: 147/64 mmHg (Inconclusive) 147/64 and 97/64 mmHg (Inconclusive) 97/64. In 2021, Body temperature: 97.6 (Inconclusive) 97.6. In 2021, Electrocardiogram: abnormal ekg in urgent care, er and cardiologist o (abnormal) Abnormal EKG in urgent care, ER and cardiologist office.. On 15-Jun-2021, Heart rate: 48 (Inconclusive) 48 beats per minute and 48 (Inconclusive) 48 beats per minute. On 21-Jun-2021, Blood pressure measurement: 111/78 mmHg (Inconclusive) 111/78 and 112/77 mmHg (Inconclusive) 112/77. On 21-Jun-2021, Heart rate: 45 (Inconclusive) 45 beats per minute and 45 (Inconclusive) 45 beats per minute.         No concomitant drugs were reported.   No treatment information was reported.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow up significant contain information of patient demographics, new events, treatment; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Patient received less than a full Moderna Covid-19 vaccine dose; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Patient received less than a full Moderna Covid-19 vaccine dose) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced UNDERDOSE (Patient received less than a full Moderna Covid-19 vaccine dose). On 21-May-2021, UNDERDOSE (Patient received less than a full Moderna Covid-19 vaccine dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.      Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Patient demographics and patient taken 2nd dose was updated
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Vaccination site pain
Clinical narrative: mild sore arm after first dose; Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) and VACCINATION SITE PAIN (mild sore arm after first dose) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 022B21A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), SERTRALINE HYDROCHLORIDE (ZOLOFT) and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 17-Dec-2020 and the estimated date of delivery was 06-Sep-2021. On 23-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On an unknown date, the patient experienced VACCINATION SITE PAIN (mild sore arm after first dose). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  eighteenth week of the pregnancy.  On 21-May-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. At the time of the report, VACCINATION SITE PAIN (mild sore arm after first dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medications were reported.